Cargando…
Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [(18)F]-Fluorodeoxyglucose Positron Emission Tomography Study
Introduction: Long-term consequences of medicinal cannabis use in people with multiple sclerosis (PwMS) are unknown. This study investigated whether PwMS using cannabis had lower resting brain glucose uptake (GU) and worse clinical test results compared with nonusers. Methods: Sixteen PwMS, eight us...
Autores principales: | Kindred, John H., Honce, Justin M., Kwak, Jennifer J., Rudroff, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186162/ https://www.ncbi.nlm.nih.gov/pubmed/30324138 http://dx.doi.org/10.1089/can.2018.0019 |
Ejemplares similares
-
Cannabis and Multiple Sclerosis—The Way Forward
por: Rudroff, Thorsten, et al.
Publicado: (2017) -
Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020) -
Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020) -
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart
por: Kong, Eunjung
Publicado: (2020)